166 related articles for article (PubMed ID: 24491927)
1. Drug and cell encapsulation: alternative delivery options for the treatment of malignant brain tumors.
Bhujbal SV; de Vos P; Niclou SP
Adv Drug Deliv Rev; 2014 Apr; 67-68():142-53. PubMed ID: 24491927
[TBL] [Abstract][Full Text] [Related]
2. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Active targeting of brain tumors using nanocarriers.
Béduneau A; Saulnier P; Benoit JP
Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
[TBL] [Abstract][Full Text] [Related]
5. Progress and challenges for cell encapsulation in brain tumour therapy.
Visted T; Lund-Johansen M
Expert Opin Biol Ther; 2003 Jul; 3(4):551-61. PubMed ID: 12831361
[TBL] [Abstract][Full Text] [Related]
6. Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier.
Miura Y; Takenaka T; Toh K; Wu S; Nishihara H; Kano MR; Ino Y; Nomoto T; Matsumoto Y; Koyama H; Cabral H; Nishiyama N; Kataoka K
ACS Nano; 2013 Oct; 7(10):8583-92. PubMed ID: 24028526
[TBL] [Abstract][Full Text] [Related]
7. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment.
Ting CY; Fan CH; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK
Biomaterials; 2012 Jan; 33(2):704-12. PubMed ID: 22019122
[TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
9. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
[TBL] [Abstract][Full Text] [Related]
10. Patented nanomedicines for the treatment of brain tumors.
Caruso G; Raudino G; Caffo M
Pharm Pat Anal; 2013 Nov; 2(6):745-54. PubMed ID: 24237240
[TBL] [Abstract][Full Text] [Related]
11. Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles.
Schneider T; Becker A; Ringe K; Reinhold A; Firsching R; Sabel BA
J Neuroimmunol; 2008 Mar; 195(1-2):21-7. PubMed ID: 18304655
[TBL] [Abstract][Full Text] [Related]
12. Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.
Chaichana KL; Pinheiro L; Brem H
Ther Deliv; 2015 Mar; 6(3):353-69. PubMed ID: 25853310
[TBL] [Abstract][Full Text] [Related]
13. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.
Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Montero-Menei C; Menei P
Biomaterials; 2011 Mar; 32(8):2106-16. PubMed ID: 21183214
[TBL] [Abstract][Full Text] [Related]
14. Use of nanoparticles for drug delivery in glioblastoma multiforme.
Jain KK
Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery to the nervous system.
Maysinger D; Morinville A
Trends Biotechnol; 1997 Oct; 15(10):410-8. PubMed ID: 9351285
[TBL] [Abstract][Full Text] [Related]
17. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
Deeken JF; Löscher W
Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
[TBL] [Abstract][Full Text] [Related]
18. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
19. The development of encapsulated cell technologies as therapies for neurological and sensory diseases.
Zanin MP; Pettingill LN; Harvey AR; Emerich DF; Thanos CG; Shepherd RK
J Control Release; 2012 May; 160(1):3-13. PubMed ID: 22285549
[TBL] [Abstract][Full Text] [Related]
20. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
Jain KK
Nanomedicine (Lond); 2012 Aug; 7(8):1225-33. PubMed ID: 22931448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
